10264-77-4Relevant academic research and scientific papers
PRMT5 INHIBITORS
-
Page/Page column 72, (2020/03/02)
The present invention provides a compound of Formula (I) Formula (I) or the pharmaceutically acceptable salts thereof, which are PRMT5 inhibitors.
HETEROCYCLIC COMPOUNDS AS PRMT5 INHIBITORS
-
Paragraph 082; 156, (2020/12/11)
The present disclosure describes novel heterocyclic PRMT5 inhibitors and methods for preparing them. The pharmaceutical compositions comprising such PRMT5 inhibitors and methods of using them for treating cancer, infectious diseases, and other PRMT5 associated disorders are also described.
